Shanghai Children's Hospital

Regional Coordination and Public Welfare Integrate Together to Write New Chapter of CPIC 2022 Sustainable Development

Retrieved on: 
Friday, April 28, 2023

In 2022, CPIC took the initiative to carry out the important regional development strategies of the county by developing sound regional development systems and building new poles of growth in key regions.

Key Points: 
  • In 2022, CPIC took the initiative to carry out the important regional development strategies of the county by developing sound regional development systems and building new poles of growth in key regions.
  • For public welfare, CPIC donated generously to charities, thus creating a rich array of charitable brands, including CPIC Green, CPIC Blue, and CPIC Red.
  • In 2021, CPIC Blue Foundation initiated a large-scale, three-year public welfare project with the theme of "protecting the memory of us all".
  • CPIC has made outstanding contributions to China's public welfare by practicing its corporate social responsibility through practical actions.

BrainCo begins clinical trials of innovative autism intervention based on Brain-Computer Interface (BCI) technology.

Retrieved on: 
Thursday, December 9, 2021

Despite broad agreement that these interventions benefit children, it remains difficult to say which type of intervention is best for the individual and how much intervention is needed.

Key Points: 
  • Despite broad agreement that these interventions benefit children, it remains difficult to say which type of intervention is best for the individual and how much intervention is needed.
  • Through clinical trials with China Autism Rehabilitation Center, Shanghai Children's Hospital and Beijing Children's Hospital, BrainCo hopes to provide some answers to these questions.
  • BrainCo's new initiative called, Cambridge StarKids Autism Rehabilitation Center, is deploying a new kind of autism intervention that combines a non-invasive EEG headband with computer-based games, activities, and exercises.
  • BrainCo was founded in 2015 by Bicheng Han, a PhD candidate at Harvard Center of Brain Science.